Alaunos Therapeutics (TCRT) Other financing activities (2010 - 2022)
Alaunos Therapeutics' (TCRT) quarterly Other financing activities came in at $21000.0 in Q3 2022, up 2000.0% YoY from $1000.0 in Q3 2021, and up 156.76% on a QoQ basis from -$37000.0 in Q4 2021.
Alaunos Therapeutics (TCRT) Other financing activities (2010 - 2022) Analysis & Trends
Alaunos Therapeutics (TCRT) has 12 years of Other financing activities data on file, last reported at $21000.0 in Q3 2022.
- Quarterly Other financing activities rose 2000.0% year-over-year to $21000.0 in Q3 2022, while the trailing twelve-month figure through Dec 2023 was $21000.0 (changed 0.0% YoY) and the FY2022 annual result came in at $21000.0, down 97.9% from the prior year.
- Other financing activities climbed to $21000.0 in Q3 2022, from -$37000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $1.0 million in Q1 2021 to a low of -$37000.0 in Q4 2021.
- A 4-year average of $201615.4 and a median of $21000.0 in 2022 frame the typical range for Other financing activities.
- The widest YoY moves for Other financing activities: up 25325.0% in 2021, down 110.36% in 2021.
- Tracing TCRT's Other financing activities over 4 years: stood at $180000.0 in 2019, then surged by 98.33% to $357000.0 in 2020, then slumped by 110.36% to -$37000.0 in 2021, then soared by 156.76% to $21000.0 in 2022.
- The last three Other financing activities figures came in at $21000.0 (Q3 2022), -$37000.0 (Q4 2021), and $1000.0 (Q3 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Alaunos Therapeutics | 4.28 Mn | 4.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 21,000.00 |
| Sep 30, 2022 | 21,000.00 |
| Dec 31, 2021 | -37,000.00 |
| Dec 31, 2021 | -37,000.00 |
| Sep 30, 2021 | 1,000.00 |
| Sep 30, 2021 | 1,000.00 |
| Jun 30, 2021 | 19,000.00 |
| Jun 30, 2021 | 19,000.00 |
| Mar 31, 2021 | 1.02 Mn |
| Mar 31, 2021 | 1.02 Mn |
| Dec 31, 2020 | 357,000.00 |
| Dec 31, 2020 | 357,000.00 |
| Sep 30, 2020 | 27,000.00 |
| Sep 30, 2020 | 27,000.00 |
| Jun 30, 2020 | 12,000.00 |
| Jun 30, 2020 | 12,000.00 |
| Mar 31, 2020 | 4,000.00 |
| Mar 31, 2020 | 4,000.00 |
| Dec 31, 2019 | 180,000.00 |
| Dec 31, 2019 | 180,000.00 |